What is Genxai Analytics IPO price?

₹116 per share. Confirm in the RHP before applying.

What is Genxai Analytics IPO GMP?

₹5 (+4.3%). Unofficial — changes daily.

When is Genxai Analytics allotment?

Expected around 10 Jun 2026. Check the registrar link on this page.

Back to IPO List

Genxai Analytics IPO

SMEListed

Allotment Status

Registrar: Bigshare Services

Check Allotment Status

Listing performance

-20.00% on listing day

Issue price

₹116

Listing price

₹92.8

Last GMP (₹)

₹5

GMP estimate

+4.31%

Actual listing gain

-20.00%

Return per lot

−₹27,840

GMP vs listing performance

GMP estimate+4.31%

Actual listing gain-20.00%

GMP pointed to +4.31% but the stock listed at -20.00% — 24.3% lower than estimated.

Listing gain calculator

Estimate profit or loss based on actual listing performance

Lots

Investment: ₹1,39,200
Listing value: ₹1,11,360
Listing gain: -20.00%
Loss (1 lot): −₹27,840

Based on issue price ₹116 × 1,200 shares per lot. Listing price ₹93. Excludes taxes, DP charges, and selling costs.

Listing results from exchange debut data where recorded. See GMP accuracy report · How we track this

Pricing Information

Price Range₹116

GMP₹5

Listing Gain4.31%

Lot Size1,200

Important Dates

Bidding Start5 Jun 2026

Bidding End9 Jun 2026

Allotment Date10 Jun 2026

Listing Date12 Jun 2026

Subscription

Overall Subscription16.99x

Additional Information

Issue Size₹54.84 Cr

Genxai Analytics IPO — Quick Analysis

Listing result:-20.0% listing loss

GMP signal:Nominal / neutral

Subscription:16.99x — oversubscribed

Genxai Analytics IPO listed on 12 Jun 2026 at an issue price of ₹116, lost 20.0% on listing day. It listed below its issue price, resulting in a loss for allottees. The issue was subscribed 16.99x overall.

Overview

Genxai Analytics is a recently listed SME IPO in India, raising ₹54.84 Cr, with shares offered around ₹116. The stock has listed with a -20.0% debut move versus the issue price. As an SME issue, expect a larger lot size and thinner post-listing liquidity than a typical Mainboard IPO.

GMP and subscription figures are unofficial market data, refreshed twice daily for active IPOs. Last updated 9 Jun 2026, 06:00 pm IST. How we source data · Disclaimer

Strengths

Subscribed 16.99x — strong demand.
Positive GMP of ₹5 (+4.3%).

Risks

Listing price can fall below issue price despite positive GMP.
SME — higher lots, lower liquidity, more volatility.
GMP is unofficial — not a confirmed listing outcome.

FAQ

Genxai Analytics IPO questions

What is Genxai Analytics IPO price?: ₹116 per share. Confirm in the RHP before applying.
What is Genxai Analytics IPO GMP?: ₹5 (+4.3%). Unofficial — changes daily.
When is Genxai Analytics allotment?: Expected around 10 Jun 2026. Check the registrar link on this page.

Livemint12 Jun 2026

Genxai Analytics share price makes weak debut; lists at ₹92.80 on NSE SME, down 20% from IPO price

Genxai Analytics listed at ₹92.80 on the NSE SME, a 20% decline from its IPO price of ₹116. The company's IPO was subscribed 16.99 times, driven by strong demand from non-institutional investors (NII) and qualified institutional buyers (QIB). The weak debut was contrary to market expectations.

Read full story

Economic Times12 Jun 2026

GenXAI Analytics shares set for listing. Here's what GMP suggests ahead of debut

GenXAI Analytics is set to list on the NSE SME platform with a grey market premium indicating a likely listing price near its issue price. The company's Rs 54.8 crore IPO was fully subscribed and aims to fund product development and working capital. GenXAI offers AI-driven enterprise performance and analytics solutions across various sectors.

Read full story

Livemint9 Jun 2026

Genxai Analytics IPO Day 3: GMP signals 5% listing gains; check subscription status and other details

Genxai Analytics IPO has received strong investor interest on its third day, with the issue set to close today. The ₹55 crore IPO comprises 0.47 crore shares priced between ₹110 and ₹116. The company plans to use the proceeds mainly for working capital and development expenses.

Read full story